Drug discovery platform for previously undruggable genome regulators, measuring a drug's effect on the entire regulome in a single native-cell experiment.
Talus Bio is a biotech company with a platform for discovering drugs that target the regulome — the control layer of transcription factors and regulatory proteins governing gene expression. Its approach measures a drug's effect on the entire regulome in one experiment within live human cells, using automated cell processing, next-generation proteomics, advanced data analytics, and AI-designed chemical libraries. This enables drug discovery for targets that fail to function properly in artificial lab systems. Talus Bio is a product of Talus Bio.